|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/86 | |
| C07K 14/445 | |||
| C07K 16/20 | |||
| C07K 14/78 | |||
| A61K 39/015 |
| (11) | Patento numeris | 2486939 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12164331.6 |
| Europos patento paraiškos padavimo data | 2008-04-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-08-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-07-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 0706914 | 2007-04-10 | GB | |
| 0717888 | 2007-09-13 | GB |
| (72) |
Reyes, Arturo, GB
Hill, Adrian, GB
O`Hara, Geraldine, GB
Colloca, Stefano, IT
Cortese, Riccardo, IT
|
| (73) |
GlaxoSmithKline Biologicals SA,
Rue de l`Institut 89, 1330 Rixensart,
BE
Oxford University Innovation Limited, Buxton Court 3 West Way, Botley Oxford OX2 0JB, GB |
| (54) | Adenoviral vector encoding malaria antigen |
| Adenoviral vector encoding malaria antigen |